HB 2528 Texas House · 89th Legislature (2025)

Relating to health benefit plan coverage of prescription drugs for opioid and substance use disorders.

HB 2528 requires most health insurance plans in Texas to cover specific medications for opioid and substance use disorders, including methadone, buprenorphine, and naltrexone. It applies to nearly all health benefit plans - such as individual/group insurance, HMOs, and health care programs - offered to Texas residents. The bill defines "medication-assisted treatment" and mandates coverage for these therapies without prior authorization or excessive cost-sharing. This policy directly affects patients seeking treatment and health insurers providing coverage in Texas. The bill does not apply to pharmacy-only services or certain specialized plans like standalone pharmacy benefit managers.
Bill status in committee 1 of 4 stages cleared
Introduction
Mar 2025
Committee Review
Floor Vote
Governor
Introduced Mar 17, 2025 Last action Apr 9, 2025
Floor votes

How they voted

No floor votes recorded yet.
Full legislative history

Actions timeline

Total actions
6
Key actions
2
Committee
3
Apr 9, 2025
Lower · Passed
Left pending in committee
lower
Apr 9, 2025
Lower · Passed
Testimony taken/registration(s) recorded in committee
lower
Mar 17, 2025
Committee
Referred to Insurance
lower
Mar 17, 2025
Introduced
Read first time
lower
1 primary · 0 co-sponsors

Sponsors

Role
Legislator
Party
State
District
P
Photo of John Bucy
John Bucy
DDemocratic
TX
136